Elixinol Global in the News


 
    The Motley Fool: Reports Elixinol Global continues to strike deals with distribution partners, which has been critical to its early success  
 
    Motley Fool: Reports on Elixinol Global's supply agreement with Pet Releaf  
 
    SmallCaps: Reports Elixinol Global strikes exclusive multimillion-dollar deal with Pet Releaf  
 
    Yahoo Finance: Reports Elixinol acquires property rights over microencapsulated technology  
 
    Yahoo Finance: Reports that Elixinol Global shares' positive performance following the release of its second quarter update.  
 
    Elixinol Global Limited excited to announce partnership with PharmaCare establishing relationships in the UK.  
 
    The Motley Fool: Reports that Elixinol Global has been granted its manufacturing licence for medicinal cannabis.  
 
    Business News Australia: Reports that Elixinol Global has restructured its board ahead of an international push.  
 
    Business Insider Australia: Reports on Elixinol Global being the first cannabis company to launch a media campaign in London Underground.  
 
    B&T: Reports on Elixinol Global's industry-first media campaign using digital signage and video boards across London Underground.  
 
    AdNews: Reports on Elixinol being the first cannabis company to advertise on London Underground.  
 
    The Motley Fool: Reports on strategic partnership between Elixinol Global and RFI through a newly incorporated Colorado based entity Infusion Strategies.  
 
    Business News Australia: Reports on Elixinol Global and RFI entering JV creating new entity Infusion Strategies  
 
    The Daily Telegraph: Reports that Elixinol Global raises $50m for US expansion  
 
    The Motley Fool: Reports Elixinol Global raises $50 million to fund its global expansion  
 
    New Cannabis Ventures: Reports on Elixinol Global selling 12.8 million shares to fund CBD growth  
 
    Stockhead: Reports Elixinol Global raises another $50m, bringing total to $120m in 18 months  
 
    Stockhead: Reports that a third of US companies selling hemp CBD products are about to disappear, and that’s actually great news!  
 
    The Motley Fool: Reports that Elixinol Global’s share price has rocketed 90% higher so far this year and is a red hot option within the industrial hemp and medicinal cannabis industries.  
 
    Seeking Alpha: Reports that Elixinol's attractive valuation and large addressable market make it an investment worth considering  
 
    Food & Drinks Business: Reports on licensing delays due to an overworked and understaffed Office of Drug Control  
 
    “Elixinol pivots to pet pot treats, nabs 25pc stake in US hemp manufacturer” reports Stockhead  
 
    Finance News Network reports “Elixinol Global to buy into pet cannabis company”  
 
    Is Elixinol Global the Fastest Growing Hemp/CBD Producer? I Streetwise Reports  
 
    Elixinol Global Signalling Significant Bullish Breakout I Insider Financial  
 
    Women are naturally drawn to medical marijuana, says Elixinol Global MD I Stockhead  
 
    Will Pot Stocks Live Up to Their Promise? I The Bull  
 
    Elixinol Global: Seeing High Profits From Diverse Investments I The Green Fund  
 
    "The Pot Seat: Elixinol’s Paul Benhaim is spending to stay on top” reports Stockhead  
 
    Elixinol Global Makes Hemp Play in $215 Million Vegan Food Sector | The Green Fund  
 
    Elixinol Global FY2018 full year results investor conference call recording  
 
    Stockhead reports that Elixinol Global (ASX:EXL) more than doubled its revenue in 2018 and expects continued financial growth this year.  
 
    Your Money interviews EXL CEO Paul Benhaim about the company’s 2018 financial results and its plans for further growth.  
 
    New Cannabis Ventures reports on Elixinol Global’s FY2018 results.  
 
    Elixinol Global is listed in Small Caps' top 10 ASX IPOs in 2018.  
 
    Insider Financial reports on Elixinol Global's international strategy and continued strong growth  
 
    Finfeed reports on Elixinol Global's recent share price increase and the company's strong financial position in the global market  
 
    Stockhead reports on Elixinol Global’s growth opportunities in the US  
 
    ABC News reveals Elixinol Global was one of the best performing stocks to debut on the ASX in 2018  
 
    AFR reports on Elixinol Global’s success in 2018  
 
    Wall Street Reporter interviews Elixinol Global CEO Paul Benhaim about EXL's progress in the CBD and hemp consumer products and foods markets  
 
    Sydney Morning Herald looks at the rise of the CBD industry, as well as the recent passage of the US Farm Bill and the positive impact this is having on Elixinol Global  
 
    Stockhead interviews Elixinol Global CEO Paul Benhaim about Australia’s medicinal cannabis regulations  
 
    Small Caps says Elixinol Global marks first shipment to New Zealand  
 
    Stockhead reports on Elixinol Global crossing the Tasman into New Zealand  
 
    Finance News Network reports on Elixinol launching in New Zealand  
 
    The Green Fund lists Elixinol Global in its Top 3 Hemp Stocks for 2019  
 
    The Motley Fool reports that Elixinol Global is up 68% in 2018  
 
    The Fly talks to Elixinol Global’s CEO about the company, competition and hemp legalisation  
 
    Streetwise Reports reveals 15 reasons why Elixinol Global should be in your portfolio  
 
    CommSec TV: Executive Series interview with Elixinol Global’s CEO, Paul Benhaim discussing the pending US Farm Bill with Tom Piotrowski  
 
    Stockhead reports on pending US Farm Bill and talks to Elixinol Global’s Paul Benhaim  
 
    Elixinol Global set to benefit from nearing of US Farm Bill legislation  
 
    US Farm Bill set to legalise and commercialise industrial hemp  
 
    Hemp’s cognitive help: Elixinol’s supplements finding favour amongst Japanese consumers  
 
    News.com.au – Cannabis expert says we’re just scratching the surface in unlocking the plant’s potential  
 
    Business News Australia reports on Elixinol Global’s strong 3Q FY2018 results  
 
    New Cannabis Ventures reports on Elixinol Global’s 3Q FY2018 revenue growth  
 
    CFN Media Interviews Elixinol’s Director of Business Development, Ruben Gonzales  
 
    The Sydney Morning Herald reports on the ‘hemp boom’ in Australia and features an interview with EXL CEO Paul Benhaim  
 
    New Cannabis Ventures says Elixinol Global raises A$40 million to expand global CBD operations  
 
    CommSec TV: Executive Series interview with Elixinol Global’s CEO, Paul Benhaim  
 
    Elixinol Global is the sleeping giant of the Hemp Market reports The Green Fund  
 
    Elixinol Global featured in Biotech Daily’s weekly column ‘Dr Boreham’s Crucible’  
 
    “Hemp is hot” and Elixinol Global is positioned to take full advantage  
 
    Elixinol Global 'only company in the sector to list a profit'  
 
    Stockhead reports Elixinol Global is one of the world’s top cannabis companies  
 
    Elixinol Global listed as the only ASX cannabis stock making a profit following its 1H FY2018 results  
 
    Sky News reports on Elixinol Global’s strong financial results  
 
    Elixinol Global doubles in size since ASX debut reports Small Caps